Immunogen reported $1.1M in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acceleron Pharma XLRN:US $ 0M 0M
Agios Pharmaceuticals AGIO:US $ 0.41M 0.59M
Amgen AMGN:US $ 37579M 4797M
Arena Pharmaceuticals ARNA:US $ 42.37M 1.13M
Astellas Pharma 4503:JP Y 310955M 37900M
AstraZeneca AZN:LN 31912M 4417M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 44742M 416M
Cerulean Pharma CERU:US $ 0M 0M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Eli Lilly And LLY:US $ 17085.4M 570.3M
Emergent Biosolutions EBS:US $ 848.9M 5.1M
Exelixis EXEL:US $ 0M 0M
Halozyme Therapeutics HALO:US $ 875.7M 0.97M
Heron Therapeutics HRTX:US $ 149.03M 0.05M
Intrexon XON:US $ 180.17M 2.89M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Macrogenics MGNX:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 34243M 1526M
Regeneron Pharmaceuticals REGN:US $ 2698.6M 1M
Seattle Genetics SGEN:US $ 0M 0M